MD simulation study showing that paratopes rigidify upon maturation.
Through over 8.5 milliseconds of molecular dynamics simulations across seven antibody lineages, the authors demonstrate that affinity maturation selectively tunes paratope dynamics by rigidifying protein-contacting regions while enhancing flexibility at glycan-contacting interfaces.
Global antibody flexibility displays no uniform trend across lineages. Intermediate antibodies often exhibit non-monotonic dynamic changes, localized conformational entropy is specifically adapted depending on the target antigen interface.
Variable region dynamics remain largely consistent regardless of whether the constant region is present or whether light chain isotypes (Kappa vs. Lambda) are swapped, proving that computational costs for all-atom simulations can be cut by at least half by simulating variable regions alone without sacrificing accuracy.
Authors perform simulations of structure to create a classifier of ASP/ASN degradation.
They use the Adimab database of 131 therapeutics where degradation rates were studied.
They look at three metrics: D1) backbone dihedral conformation of the n + 1 residue, (D2) side-chain dihedral conformation of Asn/Asp residue, (D3) fraction of time the Asn/Asp residue remains solvent accessible.
The combined model achieves accuracy of around ~.85
The best accuracy is achieved on the backbone (D1) model, indicating that this might be the most important descriptor.
Citing the Adimab study: for instance, there were 27 deamidation sites with the hotspot NG sequence in the complementary-determining region (CDR), of which only 14 underwent deamidation. A similar trend was observed in the case of isomerization (16 of 44 DG sites isomerized).
They study the ASN/ASP degradation (isomerisation and deamidation) by looking at the proton affinity
Backbone secondary structure, side-chain rotamer conformation and solvent accessibility were found to be key molecular indicators of Asp isomerization and Asn deamidation